Parkinson's disease and milacemide.
Youdim
M B
MB
D000081:Acetamides / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D005998:Glycine / Q000502:physiology; D006801:Humans; D008253:Macaca mulatta; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D009048:Motor Skills / Q000187:drug effects / Q000502:physiology; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology
D000081:Acetamides; D008996:Monoamine Oxidase Inhibitors; D016194:Receptors, N-Methyl-D-Aspartate; C039332:milacemide; D005998:Glycine